Our science is complicated, but our goal is not. Greffex's innovative, fully patented technologies are changing the future of regenerative medicine. Currently, the challenges of immune suppression in organ and tissue transplantation, gene therapy, stem cell treatments, and vaccine delivery can only be met partially, and many of today's treatments require the sacrifice of protective immune function in order to prolong life. Greffex's proprietary specific-inhibition technology offers true healing, without the need for dangerous total immune suppression.

Greffex, a multi-national company headquartered in Amsterdam, possesses a fully functional GMP facility designed to manufacture the patent-protected technology that we are currently proving in trials around the globe. Over a decade of engaging in intensive research, experimentation, and trials allows us to offer something not seen before: an elegant answer to the immune challenges posed in regenerative medicine.